Trade Mark Journal No.2025/031 1 August 2025
WO0000001853089 (5,9,42)
Office of origin: United States of America
Date of International Registration:4 October 2024
Date of designation in the UK:
4 October 2024
International priority date claimed: 4 April 2024
(United States of America)
(98485145)
International priority date claimed: 4 April 2024
(United States of America)
(98485146)
International priority date claimed: 4 April 2024
(United States of America)
(98485147)
- Class 5
- Diagnostic biomarkers for medical purposes; medical diagnostic assay for testing blood, body fluids, immune cells, or immune proteins; small molecule chemicals used as therapeutic or prophylactic agents; biologics, protein, and immune cells, excluding microbiota, for medical, therapeutic, or prophylactic purposes and development; biologics from blood, blood plasma, fractionated blood plasma, cryopaste, cryoprecipitate, or recombinant and synthetic sources for veterinary or human clinical use.
- Class 9
- Downloadable software for searching, reviewing, analyzing, testing, predicting, inferring, reconstructing, organizing, screening and sharing data, methodologies, and protocols in the fields of immunology, immunomics, immunotherapy, psychiatry, neurology, cancer, allergy, and infectious disease; downloadable electronic data files featuring datasets in the fields of immunology, immunomics, immunotherapy, psychiatry, neurology, cancer, allergy, and infectious disease.
- Class 42
- Creating, designing and improving of methods for identifying etiology, treatment, and prophylaxis of chronic diseases, autoimmunity, psychiatric disorders, neurological disorders, cancer, allergy, and infectious disease; creating, designing and improving of datasets in the fields of immunology, immunomics, immunotherapy, psychiatry, neurology, cancer, allergy, and infectious disease; providing temporary use of non-downloadable software for searching, reviewing, analyzing, testing, predicting, inferring, reconstructing, organizing, screening and sharing data, methodologies, and protocols in the fields of immunology, immunomics, immunotherapy, psychiatry, neurology, cancer, allergy, and infectious disease; providing an online database of scientific information in the field of immunology, immunomics, immunotherapy, psychiatry, neurology, cancer, allergy, and infectious disease; creating, designing and improving of testing assays and screening platforms in the fields of immunology, immunomics, immunotherapy, psychiatry, neurology, cancer, allergy, and infectious disease; providing information about methods for identifying etiology, treatment, and prophylaxis of chronic diseases, autoimmunity, psychiatric, neurological disorders, cancer, allergy, and infectious disease; creating, designing, building, and improving testing, screening, prediction, inference, reconstruction, and analysis platforms and models to identify pharmaceutical drug and biologics candidates for clinical and veterinary use.
Imprint Labs, LLC
Representative: Stacy E. Don Law Office of Stacy E. Don, 3500 Douglas Blvd., Suite 210, Roseville CA 95661, UNITED STATES OF AMERICA